Nuvation Bio Inc (NUVB) PT Raised at RBC Capital; ' High-reward opportunity looks compelling'
Tweet Send to a Friend
RBC Capital analyst Leonid Timashev raised the price target on Nuvation Bio Inc (NYSE: NUVB) to $20.00 (from $13.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
